Protein S exacerbates alcoholic hepatitis by stimulating liver natural killer T cells.
BACKGROUND
Alcohol consumption is a major cause of liver injury but the mechanisms are not completely understood. Protein S (PS) is an anticoagulant glycoprotein with multiple functions. The role of PS in liver injury is unknown.


OBJECTIVE
This study investigated the role of PS in acute alcoholic hepatitis.


METHODS
A mouse overexpressing human PS (hPS-TG) was generated in which acute hepatitis was induced by intraperitoneal injection of ethanol.


RESULTS
The levels of serum liver enzymes and liver tissue inflammatory cytokines and the degree of hepatic steatosis were significantly increased in hPS-TG mice treated with ethanol compared with ethanol-treated wild type (WT) mice. Cell expansion, activation and inhibition of apoptosis were significantly augmented in natural killer T (NKT) cells from hPS-TG mice compared with WT mice. Liver mononuclear cells from hPS-TG mice express higher levels of inflammatory cytokines than those from WT mice after stimulation with a specific stimulant of NKT cells in vitro. In a co-culture system of hepatocytes and NKT cells, the effects of PS on ethanol-mediated cell injury were suppressed by a CD1d neutralizing antibody. Alcoholic liver injury was significantly improved in mice pre-treated with PS siRNA and anti-protein S antibody compared with control mice. Patients with alcoholic hepatitis showed significantly increased plasma PS levels and enhanced liver expression of PS and CD1d compared with controls.


CONCLUSIONS
The results of this study suggest that PS exacerbates acute alcoholic hepatitis by inhibiting apoptosis of activated NKT cells.
Department of Immunology, Mie University Graduate School of Medicine, Tsu, Mie, Japan.
A-L
AL
Chelakkot-Govindalayathil
R
R
Mifuji-Moroka
C N
CN
D'Alessandro-Gabazza
M
M
Toda
Y
Y
Matsuda
P
P
Gil-Bernabe
Z
Z
Roeen
T
T
Yasuma
Y
Y
Yano
E C
EC
Gabazza
M
M
Iwasa
Y
Y
Takei
D000818:Animals; D057134:Antibodies, Neutralizing / Q000494:pharmacology; D055610:Antigens, CD1d / Q000276:immunology / Q000378:metabolism; D017209:Apoptosis; D001798:Blood Proteins / Q000235:genetics / Q000378:metabolism*; D016022:Case-Control Studies; D002478:Cells, Cultured; D018920:Coculture Techniques; D004195:Disease Models, Animal; D000431:Ethanol; D005235:Fatty Liver, Alcoholic / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D006519:Hepatitis, Alcoholic / Q000235:genetics / Q000276:immunology / Q000378:metabolism* / Q000473:pathology / Q000517:prevention & control; D022781:Hepatocytes / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D006801:Humans; D018836:Inflammation Mediators / Q000276:immunology / Q000378:metabolism; D008099:Liver / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D008213:Lymphocyte Activation; D008297:Male; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D055611:Natural Killer T-Cells / Q000276:immunology / Q000378:metabolism*; D017293:Protein S / Q000235:genetics / Q000378:metabolism*; D000067492:RNAi Therapeutics; D012720:Severity of Illness Index; D015398:Signal Transduction; D015854:Up-Regulation
D057134:Antibodies, Neutralizing; D055610:Antigens, CD1d; D001798:Blood Proteins; C584692:CD1d antigen, mouse; D018836:Inflammation Mediators; C523390:PROS1 protein, human; D017293:Protein S; D000431:Ethanol
alcoholism; anticoagulants; hepatitis; natural killer T cells; protein S